|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sulprofos | CAS 35400-43-2 | ||
| C12H19O2PS3 | RTECS TE4165000 | ||
|
Synonyms & Trade Names Bolstar®, O-Ethyl O-(4-methylthio)phenyl S-propylphosphorodithioate |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 1 mg/m3 | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion 1 ppm = 13.19 mg/m3 | ||
|
Physical Description Tan-colored liquid with a sulfide-like odor. |
|||
|
MW: 322.5 |
BP: ? |
FRZ: ? |
Sol: Low |
|
VP: <8 mmHg |
IP: ? |
|
Sp.Gr: 1.20 |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods NIOSH 5600; PV2037 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: No recommendation Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, ingestion | |
| Symptoms Nausea, vomiting, abdominal cramps, diarrhea, salivation; headache, dizziness, lassitude (weakness, exhaustion); rhinorrhea (discharge of thin mucus), chest tightness; blurred vision, miosis; cardiac irregularities; muscle fasciculation; dyspnea (breathing difficulty) | |
|
Target Organs
respiratory system, central nervous system, cardiovascular system, blood cholinesterase |
|
| See also: INTRODUCTION |